- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06518265
Osteosynthesis of High-Risk Ankle Fractures Using Locked Fibula Nails: What Results for Which Patients? (OFCCF)
Osteosynthesis of High-Risk Ankle Fractures Using Locked Fibula Nails: What Results for Which Patients? A Monocentric Case Series
Ankle fractures are among the most common injuries in orthopedic and trauma surgery, accounting for 9% of all fractures. They can be classified into isolated malleolar fractures (internal and/or external), pilon fractures, and distal tibia fractures, which affect the entire distal part of the tibia, depending on whether they are intra-articular or extra-articular.
The aging of the population and the increase in survival of multiple trauma patients lead to an increase in ankle fractures with high skin risk, whether due to an open fracture, soft tissue injury (crush, dermabrasion, etc.). ) or a major risk of scarring (chronic venous insufficiency, lymphedema, unbalanced diabetes.
The fibula nail is a recent, minimally invasive osteosynthesis method whose results seem at least equivalent to those of screwed plate osteosynthesis in numerous series in the literature. The most commonly used and most studied fibula nail in the literature is the Acumed fibula nail. In recent literature, the use of the fibula nail in the fixation of tibial pilon fractures and/or fractures of the distal quarter of the leg is associated with satisfactory results.
The elements collected as part of this study could make it possible to validate the use of the fibula nail in the management strategy for these fractures and thus better codify and standardize practices in this restricted and complex area of traumatology.
Study Overview
Status
Detailed Description
Ankle fractures represent one of the most common injuries in orthopedic and trauma surgery with an incidence of 9% of all fractures. We distinguish between isolated fractures of the malleolus (internal and/or external), fractures of the tibial pilon and the distal quarter of the leg which concern the entire distal part of the tibia depending on whether they are intra- or extra-articular. The aging of the population and the increase in survival of multiple trauma patients lead to an increase in ankle fractures with high skin risk, whether due to an open fracture, soft tissue injury (crush, dermabrasion, etc.). ) or a major risk of scarring (chronic venous insufficiency, lymphedema, unbalanced diabetes, etc.).
The classic management of fractures of the fibula (external malleolus) is based on open reduction-fixation using a screwed plate, made through a longitudinal incision. Restoring the length of the fibula contributes to the reduction of fractures of the tibial pilon. However, in patients at high skin risk, plate fixation increases tissue trauma and can lead to scar complications and infections.
The fibula nail is a recent, minimally invasive osteosynthesis method whose results seem at least equivalent to those of screwed plate osteosynthesis in numerous series in the literature [BÄCKER 2019]. The most commonly used and most studied fibula nail in the literature is the Acumed fibula nail. In recent literature, the use of the fibula nail in the fixation of tibial pilon fractures and/or fractures of the distal quarter of the leg is associated with satisfactory results.
If the fibula nail seems equivalent to the screwed plate in "classic" ankle fractures, we can wonder if its minimally invasive nature does not give it an advantage over the screwed plate in the fixation of ankle fractures. high skin risk. To our knowledge, few series have been published concerning this subpopulation at risk and for which the fibula nail represents an interesting alternative.
Likewise, although a biomechanical study showed a higher rate of torsional fracture after fibula nail fixation versus screwed plate, the results of fibula nail fixation in unstable ankle fractures appear equivalent to those of fixing by screwed plates. As the notion of stability of ankle fractures is not clearly defined in the literature, we will refer to tri-malleolar fractures, dislocated bi-malleolar fractures, tibial pilon fractures and fractures of the distal quarter of the leg as unstable fractures. As the notion of skin risk is not clearly defined in the literature, we will designate as skin risk patients presenting with acute traumatic tissue damage associated or not with an open fracture evaluated according to the Oestern and Tscherne classification as well as patients presenting with a skin disease. chronic such as lipodermatosclerosis, lymphedema, varicose or arterial ulcer and skin atrophy secondary to long-term corticosteroid therapy compromising the healing of a longitudinal incision next to the fibula.
Expected benefits:
The elements collected as part of this study could make it possible to validate the use of the fibula nail in the management strategy for these fractures and thus better codify and standardize practices in this restricted and complex area of traumatology.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mehdi PI BOUDISSA, Pr
- Phone Number: 0033476769693
- Email: MBoudissa@chu-grenoble.fr
Study Contact Backup
- Name: Sarah KASSAR-UNEISI, Pharm-D
- Phone Number: 0033476767524
- Email: SUneisi@chu-grenoble.fr
Study Locations
-
-
-
La Tronche, France, 38700
- Recruiting
- Grenoble Alpes University Hospital,La tronche
-
Principal Investigator:
- Mehdi BOUDISSA, Pr
-
Contact:
- Sarah PI KASSAR-UNEISI, Pharm D
- Phone Number: 0033476767524
- Email: suneisi@chu-grenoble.fr
-
Sub-Investigator:
- Guillaume VEYRAT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
This single-center observational study selects all patients treated in the orthopedics and traumatology department at Grenoble Alpes University Hospital between 01/01/2021 and 12/31/2023 for an unstable ankle fracture with high cutaneous risk.
Epidemiological data, preoperative management, operative data and radiological criteria are collected and analyzed retrospectively.
Description
Inclusion Criteria:
- Adult patient at the time of injury
- Unstable fracture of one or both ankles: tri-malleolar fracture, distal quarter of the leg, tibial pilon.
- High skin risk (acute traumatic tissue injury associated or not with an open fracture evaluated according to the Oestern and Tscherne classification, chronic skin disease such as lipodermatosclerosis, lymphedema, varicose or arterial ulcer and skin atrophy secondary to corticosteroid therapy long course compromising the healing of a longitudinal incision next to the fibula).
- Standard preoperative x-ray image (ankle face and profile)
- Standard image post-operative x-rays (ankle face and profile)
- No opposition to participation in the study.
Exclusion Criteria:
- Pregnant, breastfeeding women.
- Subject under guardianship, curatorship, deprived of liberty or under the protection of justice.
- Subject who are cognitively incapable of answering the questionnaire.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the clinical and radiological results of patients treated for fixation of an unstable ankle fracture with high cutaneous risk including a fibula nail without access to the fibular fracture site.
Time Frame: 1 year
|
obtaining bone consolidation (healing) without cutaneous complications.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the quality of the radiological reduction.
Time Frame: 1 year
|
Radiological criteria of McLenann
|
1 year
|
|
Evaluation of clinical results
Time Frame: 1 year
|
Clinical scores of EFAS
|
1 year
|
|
Evaluation of clinical results
Time Frame: 1 year
|
Clinical scores of Olerud and Molander
|
1 year
|
|
Evaluation of clinical results
Time Frame: 1 year
|
Clinical scores of Kitaoka hindfoot
|
1 year
|
|
Assessment of complications
Time Frame: 1 year
|
Complications: re-intervention(s)
|
1 year
|
|
Assessment of complications
Time Frame: 1 year
|
Complications: infection
|
1 year
|
|
Assessment of complications
Time Frame: 1 year
|
Complications: healing disorders
|
1 year
|
|
Assessment of complications
Time Frame: 1 year
|
Complications: secondary displacement
|
1 year
|
|
Assessment of complications
Time Frame: 1 year
|
Complications: discomfort of osteosynthesis equipment
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-A00925-42
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.